If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Director/PDMR Shareholding

26 Jan 2017 10:10

RNS Number : 2106V
Scapa Group PLC
26 January 2017
 

26 January 2017

SCAPA GROUP PLC

('the Company')

Director/PDMR Notification

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Scapa Group plc (AIM: SCPA), a global supplier of bonding solutions and manufacturer of adhesive-based products for the Healthcare and Industrial markets, was notified on 25 January 2017 that James Archibald Simpson Wallace, Group Chairman of the Company, sold 150,000 ordinary shares of 5 pence each in the share capital of the Company ('Ordinary Shares') at a price of 320 pence per Ordinary Share and 250,000 ordinary shares of 5 pence each in the share capital of the Company ('Ordinary Shares') at a price of 321 pence per Ordinary Share on 25 January 2017, as detailed below.

On 15 December 2016, Mr Wallace announced his retirement as Chairman of the Board of Scapa Group plc with effect from 31 March 2017, at which point Mr Larry Pentz will assume Chairmanship.

Following the sale Mr. Wallace holds 70,000 Shares in the Company.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

James Archibald Simpson Wallace

 

2

Reason for the notification

a)

Position / status

Group Chairman

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of financial instrument,

type of instrument

 

Ordinary shares of 5p each

Identification Code

GB0007281198

b)

Nature of the transaction

Sale of shares

 

c)

Price(s) and volume(s)

 

Sale of 150,000 shares at 320p per share

Sale of 250,000 shares at 321p per share

d)

Aggregated information

- Aggregated volume

- Price

 

n/a

e)

Date of the transaction

25 January 2017

f)

Place of the transaction

London

 

For further information please contact:-

 

Graham Hardcastle Group Finance Director/Company Secretary

Scapa Group plc

Tel: 0161 301 7400

 

Richard Thomas Numis Securities Limited

Nominated Adviser and Joint Broker

Tel: 0207 260 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUNRRRBKAAUAR
Date   Source Headline
1st Mar 201710:22 amRNSAdditional Listing
23rd Feb 201711:03 amRNSHolding(s) in Company
16th Feb 20179:21 amRNSHolding(s) in Company
7th Feb 20174:16 pmRNSBlock listing Interim Review
3rd Feb 20173:53 pmRNSHolding(s) in Company
26th Jan 201710:10 amRNSDirector/PDMR Shareholding
25th Jan 20174:33 pmRNSBlock listing Interim Review
25th Jan 201711:49 amRNSHolding(s) in Company
23rd Jan 20179:18 amRNSDirector/PDMR Shareholding
9th Jan 20179:41 amRNSAdditional Listing
22nd Dec 20162:15 pmRNSAdditional Listing
15th Dec 20167:00 amRNSDirectorate Change
13th Dec 20161:29 pmRNSAdditional Listing
24th Nov 20164:30 pmRNSDirector/PDMR Shareholding
24th Nov 20164:20 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:20 pmRNSAdditional Listing
22nd Nov 20167:00 amRNSHalf-year Report
12th Oct 20167:00 amRNSTrading Statement
27th Sep 20162:53 pmRNSDirector/PDMR Shareholding
21st Sep 20161:51 pmRNSAdditional Listing
6th Sep 201610:24 amRNSAdditional Listing
2nd Sep 201611:20 amRNSBlock listing Interim Review
31st Aug 20169:14 amRNSTotal Voting Rights
26th Aug 20167:00 amRNSDirector/PDMR Shareholding
12th Aug 201611:24 amRNSBlock listing Interim Review
11th Aug 20161:30 pmRNSDirector/PDMR Shareholding
10th Aug 201610:08 amRNSDirector/PDMR Shareholding
19th Jul 20164:58 pmRNSAdditional Listing
19th Jul 20167:00 amRNSAGM Statement
11th Jul 20163:48 pmRNSDirector/PDMR Shareholding
5th Jul 20162:25 pmRNSHolding(s) in Company
1st Jul 20162:58 pmRNSDirector/PDMR Shareholding
1st Jun 20163:49 pmRNSAdditional Listing
1st Jun 20167:00 amRNSAppointment of Joint Broker
24th May 20167:00 amRNSAcquisition
24th May 20167:00 amRNSFinal Results
18th May 201610:01 amRNSAdditional Listing
11th May 201610:45 amRNSHolding(s) in Company
18th Apr 20167:00 amRNSDirectorate Change
14th Apr 20167:00 amRNSTrading Statement
2nd Mar 20169:06 amRNSBlocklisting Interim Review
8th Feb 20169:49 amRNSBlocklisting Interim Review
28th Jan 20167:00 amRNSDirectorate Change
31st Dec 20157:00 amRNSTotal Voting Rights
15th Dec 20159:57 amRNSHolding(s) in Company
14th Dec 20158:26 amRNSHolding(s) in Company
14th Dec 20158:21 amRNSDirector/PDMR Shareholding
8th Dec 201511:46 amRNSHolding(s) in Company
8th Dec 201511:42 amRNSHolding(s) in Company
1st Dec 201510:52 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.